The Impact of Pharmacokinetic-Guided Prophylaxis on Clinical Outcomes and Healthcare Resource Utilization in Hemophilia A Patients: Real-World Evidence from the CHESS II Study

BACKGROUND: Using a pharmacokinetic (PK)-guided approach to personalize the dose and frequency of prophylactic treatment can help achieve and maintain targeted factor VIII (FVIII) trough levels in patients with hemophilia A. OBJECTIVE: Investigate clinical and healthcare resource use outcomes in pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferri Grazzi, Enrico, Sun, Shawn X, Burke, Tom, O’Hara, Jamie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9507282/
https://www.ncbi.nlm.nih.gov/pubmed/36157322
http://dx.doi.org/10.2147/JBM.S363028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9507282/
https://www.ncbi.nlm.nih.gov/pubmed/36157322
http://dx.doi.org/10.2147/JBM.S363028

Ejemplares similares